α-Glucosidase-IN-22

α-Glucosidase-IN-22

Cat. No.: DIA-0243259

Size: 10 mg Size: 25 mg Size: 50 mg Size: 100 mg Size: Customer Size
Product Information
CAS No. 2870693-28-8
Formula C14H11N3O2S
Molecular Weight 285.32
SMILES S=C1NC2=CC=C(C=C2N1)/N=C/C3=CC=C(C=C3O)O
Target Glucosidase
Product Description α-Glucosidase-IN-22 (compound 7i), a benzimidazole, is a potent α-glucosidase inhibitor with an IC50 of 0.64 μM. α-Glucosidase-IN-22 is a potent anti-diabetic agent and has the potential for type 2 diabetes mellitus (T2DM) research.
Format & Storage
Format Solid
Color Light yellow to yellow
Purity 99.13%
Shipping Room temperature in the continental U.S. Other areas may vary.
Storage Powder: -20°C, 3 years; 4°C, 2 years In solvent: -80°C, 6 months; -20°C, 1 month
Solubility Overview Soluble in DMSO
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
logo

Ace Therapeutics has a team of wellknown experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.

Quick Links
Contact Info
Copyright © Ace Therapeutics. All Rights Reserved.
Top